Epigenetic and epitranscriptomic networks have important functions in maintaining the pluripotency of embryonic stem cells (ESCs) and somatic cell reprogramming. However, the mechanisms integrating the actions of these distinct networks are only partially understood. Here we show that the chromatin-associated zinc finger protein 217 (ZFP217) coordinates epigenetic and epitranscriptomic regulation. ZFP217 interacts with several epigenetic regulators, activates the transcription of key pluripotency genes, and modulates N6-methyladenosine (m 6 A) deposition on their transcripts by sequestering the enzyme m 6 A methyltransferase-like 3 (METTL3). Consistently, Zfp217 depletion compromises ESC self-renewal and somatic cell reprogramming, globally increases m 6 A RNA levels, and enhances m 6 A modification of the Nanog, Sox2, Klf4, and c-Myc mRNAs, promoting their degradation. ZFP217 binds its own target gene mRNAs, which are also METTL3 associated, and is enriched at promoters of m 6 A-modified transcripts. Collectively, these findings shed light on how a transcription factor can tightly couple gene transcription to m 6 A RNA modification to ensure ESC identity.
In Brief Aguillo et al. show that ZFP217 coordinates epigenetic and epitranscriptomic networks to control embryonic stem cell pluripotency and somatic cell reprogramming. ZFP217 directly activates core stem cell genes and restrains m 6 A deposition in their transcripts through interaction with METTL3, coupling transcription and mRNA methylation to control stemness.
INTRODUCTION
Embryonic stem cell (ESC) self-renewal and somatic cell reprogramming require the precise coordination of transcription factors, chromatin regulators, and RNA modifiers to be sustained.
Considerable efforts have been devoted to characterizing the epigenetic and transcription networks controlling pluripotency. However, the function of post-transcriptional RNA modifications maintaining the equilibrium between ESC self-renewal and differentiation remains poorly understood. Zinc finger protein 217 (Zfp217) encodes a transcription factor with eight conserved C 2 H 2 zinc finger motifs and a proline-rich transactivation domain. Overexpression and/or genetic amplification of the human homolog ZNF217 correlates with poor survival in a variety of cancers (reviewed by Quinlan et al., 2007) . Human mammary epithelial cells or ovarian cells transduced with ZNF217 bypass senescence and achieve an immortalized state (Li et al., 2007; Nonet et al., 2001 ), a hallmark of both cancer and stem cells. Overexpression of ZNF217 provides a selective advantage to tumor cells by deregulating pathways associated with normal growth, apoptosis, or differentiation (Huang et al., 2005; Thollet et al., 2010) , in part through INK4B locus repression (Thillainadesan et al., 2012) . ZNF217 has also been associated with Aurora kinase A overexpression (Thollet et al., 2010) and with the activation of the transforming growth factor b (TGF-b) (Vendrell et al., 2012) and AKT pathways (Huang et al., 2005) , required to maintain pluripotency (Boiani and Schö ler, 2005; Lee et al., 2012; Welham et al., 2011) . Moreover, induced differentiation of Ntera2 cells with retinoic acid leads to downregulation of ZNF217 (Krig et al., 2007) . Despite increasing observations supporting a function of ZNF217 in the maintenance of the undifferentiated state, the role of this transcription factor in ESC biology remains unexplored.
Recent studies propose that N6-methyladenosine (m 6 A), the most abundant post-transcriptional modification in RNA (Jia et al., 2013; Tuck, 1992) , can determine the fate of ESC selfrenewal and pluripotency (Wang et al., 2014b) , whereas others postulate that m 6 A is required for the transition to differentiated states (Batista et al., 2014; Geula et al., 2015) . The core mammalian methyltransferase complex includes methyltransferase-like (Liu et al., 2014; Ping et al., 2014) . Enrichment of m 6 A in RNA effectively influences all aspects of RNA metabolism, including mRNA stability (Wang et al., 2014a (Wang et al., , 2014b , alternative splicing (Fustin et al., 2013; Geula et al., 2015; Ping et al., 2014; Zhao et al., 2014) , mRNA translation efficiency (Geula et al., 2015) , and secondary RNA structure and localization, resulting in alterations in an array of cellular processes. Nonetheless, the molecular function of m 6 A RNA modification in development remains incompletely understood.
In this study, we elucidate the multi-faceted role of ZFP217 in pluripotency. We show that ZFP217 directly activates the transcription of Nanog, Sox2, and many other genes linked to the undifferentiated state. Furthermore, ZFP217 restricts the deposition of m 6 A at these transcripts through METTL3 interaction.
Depletion of Zfp217 results in a decrease in the expression of pluripotency factors and a global increase of m 6 A methylation, promoting the degradation of core stem cell transcripts. Taken together, these findings demonstrate that ZFP217 is an essential regulator that balances self-renewal and differentiation not just by regulating the epigenome but also the epitranscriptome of pluripotency-associated factors.
RESULTS

Loss of Zfp217 Impairs Self-Renewal and Triggers Differentiation in ESCs
To explore the function of ZFP217 in ESCs, we analyzed the expression of Zfp217 in mouse embryonic fibroblasts (MEFs), ESCs, and induced pluripotent stem cells (iPSCs) by qRT-PCR. Zfp217 was significantly enriched in ESCs and iPSCs compared with MEFs ( Figure 1A ). Examination of Zfp217 expression in retinoic acid (RA)-induced differentiation and in embryoid bodies (EBs) revealed a gradual decrease in Zfp217 levels, but not Zfp617, along the course of differentiation, which correlated with the decrease of Nanog, Pou5f1 (also known as Oct3/4), and Sox2 (Figures 1B and 1C) . In agreement with these findings, Zfp217 RNA and ZFP217 protein levels were decreased upon short hairpin RNAs (shRNAs) of the pluripotency factors Nanog, Pou5f1, and Sox2 ( Figures 1D and 1E ). Next we conducted lossof-function assays by using two distinct shRNAs that exhibited at least 80% knockdown of endogenous ZFP217 protein and Zfp217 RNA in ESCs ( Figure 1F ). Although control cells retained ESC morphology, Zfp217-depleted cells exhibited a flattened fibroblastic-like morphology typical of differentiating ESCs, with decreased levels of alkaline phosphatase (AP) staining (Figure 1G) . Specifically, Zfp217 depletion increased the number of partially and fully differentiated colonies, whereas the number of undifferentiated colonies decreased drastically ( Figure 1H ). Furthermore, loss of Zfp217 resulted in severely compromised cell growth ( Figure 1I ), an impaired cell-cycle profile ( Figure 1J ), and a marked increase in early apoptosis ( Figure 1K ). Taken together, these results suggest that ZFP217 is required to maintain the pluripotency state of ESCs.
Somatic Cell Reprogramming Is Impaired upon Zfp217
Knockdown Given the role of ZFP217 in the maintenance of ESC identity, we examined ZFP217 function during iPSC reprogramming. We transduced MEFs by lentiviral infection with a polycistronic cassette constitutively expressing the Yamanaka factors (OCT4, SOX2, KLF4, and c-MYC [OSKM]) ( Figure 2A ; Takahashi et al., 2007; Takahashi and Yamanaka, 2006) , and we observed upregulation of both Zfp217 and Nanog during mouse iPSC generation ( Figures 2B and 2C) . Next, the ectopic expression of OSKM was combined with either control or Zfp217 shRNA, being the transduction efficiency comparable under both conditions ( Figure S1A ). Depletion of Zfp217 in reprogrammable MEFs markedly reduced the number of AP-positive iPSC colonies, suggesting that ZFP217 plays a positive role in iPSC generation (Figures 2D and 2E) . Importantly, depletion of Zfp217 did not affect the proliferation of reprogramming MEFs ( Figure 2F ), indicating that the decrease in iPSC number is not due to adverse effects on the proliferative capacity of transduced MEFs. Isolated iPSC clones originated from Zfp217 shRNA-transduced MEFs were not bona fide iPSCs because they exhibited significantly decreased expression of Zfp217 and Nanog relative to control shRNA (Figures S1B and S1C). A positive role in reprogramming was further supported by ZFP217 overexpression, with a substantial increase in iPSC colony numbers ( Figures 2G-2J ).
Reprogramming is a multi-step process initiated by enhanced proliferation, followed by mesenchymal-to-epithelial transition (MET) (Li et al., 2010) , and completed by activation of pluripotency genes. To identify what stage of reprogramming was blocked upon Zfp217 depletion, we performed immunofluorescence microscopy for E-CADHERIN (CDH1), the hallmark of epithelial cell identity, the stem cell marker stage-specific embryonic antigen 1 (SSEA1), and NANOG on days 5, 10, and 15 after OSKM reprogramming in the presence of control or Zfp217 shRNA. CDH1 and SSEA1 were activated by day 5 post-infection, even in the absence of ZFP217 ( Figure 2K ). Conversely, NANOG was not activated on day 10 post-transduction, and its expression remained undetectable on day 15 in reprogramming MEFs depleted of Zfp217 ( Figure 2K ). Consistently, the elevation of several pluripotency genes was impaired upon loss of Zfp217, whereas the expression of most epithelial and mesenchymal genes analyzed was unaffected in Zfp217-depleted reprogramming MEFs compared with the control (Figure 2L ; Figures S1D-S1O ). Overall, our results indicate that ZFP217 is required for the generation of iPSCs from MEFs, being predominantly indispensable for later stages of somatic cell reprogramming, when activation of the pluripotency factors occurs.
ZFP217 Positively Regulates the ESC Transcriptome
To gain an overview of the global role of ZFP217 in pluripotency, we performed chromatin immunoprecipitation followed by massively parallel sequencing (ChIP-seq) and RNA sequencing (RNA-seq) in control and Zfp217 knockdown ESCs. Analysis of ZFP217 binding identified 10,406 target genes ( Table S1 ) that were more likely to be regulated upon Zfp217 knockdown when the binding peak was located at the transcription start site (TSS) ( Figure 3A ). Nevertheless, despite the fact that all regulated genes in Zfp217-depleted ESCs were bound by ZFP217, they represented only a minority of ZFP217 ChIP-seq targets ( Figure 3B ) and were not associated with genes important for ESC identity (data not shown). RNA-seq analysis revealed 882 upregulated genes (Table S1) in Zfp217-depleted ESCs that associated with gene ontology (GO) categories related to RNA metabolic processes and transcription ( Figure 3C ), whereas the 2,058 downregulated genes upon Zfp217 knockdown (Table  S1 ) were involved in diverse functions ( Figure 3D ). Analysis of peak distribution showed that ZFP217 predominantly occupied promoters (within 5 kb of the annotated TSS) and intergenic regions of actively transcribed and bivalent genes (Figures 3E-3G ; Figures S2A-S2C ). Because human ZNF217 is associated with the corepressor for element 1-silencing transcription factor (CoREST) (Cowger et al., 2007; Lee et al., 2005; You et al., 2001) , we examined the overlap between ZFP217 and the previously published REST cofactors (SIN3A/B) and CoREST complex (RCOR1, RCOR2, and RCOR3) datasets. Our analysis revealed that the vast majority of genes occupied by some of the CoREST members were enriched with ZFP217 ( Figure S2D ). In accordance with the fact that the CoREST complex is implicated in neuronal differentiation (Yu et al., 2011) , the ZFP217-bound bivalent genes functioned in commitment to the neural lineage ( Figure S2E ). Next, we performed de novo motif analysis using the algorithm multiple EM for motif elicitation (MEME) and identified a unique DNA motif enriched at ZFP217 sites ( Figure 3H ) that overlapped with the binding sequence for STAT3 ( Figure 3I ). Secondary motifs overrepresented in ZFP217-bound regions included known binding sequences for KLF4, SP1, and POU5F1 ( Figure 3I ), among others, suggesting that ZFP217 might occupy an overlapping set of genomic sites important for the regulation of the undifferentiated state. In agreement with this observation, inspection of individual gene tracks of ZFP217 and publicly available POU5F1 datasets showed ZFP217 and POU5F1 binding at the core promoter and at the enhancers of Pou5f1, Nanog, and Sox2 ( Figures S3A-S3C ). Moreover, RNA-seq profiling revealed a significant decrease of key ESC transcripts upon Zfp217 depletion ( Figures 4A and 4B ), suggesting an important role for ZFP217 in regulating the expression of stem cell identity genes. Further expression analysis revealed that levels of ectodermal and endodermal markers, but not trophectodermal and mesodermal markers, were increased in Zfp217 knockdown ESCs ( Figures S3D-S3G ), suggesting that the repressor activity of ZFP217 on developmental genes is also important for ESC maintenance. To further determine whether ZFP217 directly regulates the expression of genes encoding the core pluripotency factors, we cloned the well characterized Nanog, Pou5f1, and Sox2 enhancers into the Oct4 minimal promoter and transfected these reporters into either control or Zfp217-depleted ESCs. A significant decrease in luciferase activity upon Zfp217 knockdown suggested a direct regulation ( Figure 4C ), which was further validated by ChIP-qPCR of ZFP217 ( Figure 4D ). Because lysine demethylase 1 (LSD1), a known interacting partner of ZFP217 involved in enhancer decommissioning of pluripotency genes (Whyte et al., 2012) , also bound these genomic regions (Figure 4D ; Figures S3A-S3C), we reasoned that the overlap of ZFP217, LSD1, and POU5F1 genome-wide binding might reveal the occupancy of the stem cell identity genes. Indeed, ZFP217, LSD1, and POU5F1 co-occupied hundreds of sites in the ESC genome ( Figure S3H ), which was supported by heatmap clustering of the read density, where an enriched signal was prevalent surrounding the center of ZFP217 binding sites ( Figure 4E ). Nevertheless, additional elements must be required for this association because co-immunoprecipitation experiments showed interaction between ZFP217 and LSD1 but not with POU5F1 ( Figure S3I ). Expectedly, ZFP217-LSD1-POU5F1 target genes were enriched in undifferentiated cells compared with RA-induced differentiated cells (Table S2) or EBs ( Figure 4F , top) and were associated with an ESC identity signature (Figure 4F, bottom) . Accordingly, ZFP217 localized at superenhancers, identified at genes important for the maintenance of pluripotency ( Figure S3J ; Whyte et al., 2013) . Overall, our findings indicate that ZFP217 globally contributes to the transcriptional program that maintains the expression of core stem cell genes to preserve ESC self-renewal.
ZFP217 Interacts with METTL3 and Negatively Affects m 6
A Deposition To gain insight into the molecular mechanism by which ZFP217 controls ESC maintenance and somatic cell reprogramming, we performed immunoprecipitation experiments with endogenous ZFP217 in ESCs, followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). We identified ZFP217 as well as peptides representative of LSD1, RCOR1, RCOR2, C-terminal-binding proteins 1 (CTBP1) and 2 (CTBP2), and histone deacetylase 1 (HDAC1), consistent with previously reported binding partners of ZNF217, and, therefore, validating our approach (Banck et al., 2009; Cowger et al., 2007; Quinlan et al., 2006; You et al., 2001 ; Figure 5A ; Table S3 ). Interestingly, we also identified numerous proteins involved in RNA post-transcriptional modification, including mRNA and rRNA processing, rRNA maturation and splicing, and methylation, among others ( Figure 5B ).
We focused our attention on the interaction of ZFP217 with the RNA methyltransferase METTL3 because the regulation and function of m 6 A mRNA in ESCs remains largely unknown. Although ZFP217 has not been identified as a METTL3-interacting protein in recent studies (Liu et al., 2014; Schwartz et al., 2014) , we could verify a robust and specific association between ZFP217 and METTL3 in ESCs by co-immunoprecipitation (Figure 5C, left) and reverse coIP experiments of the endogenous proteins ( Figure 5C , right). Consistent with the fact that METTL14 was not present in our LC-MS/MS analysis, we could not detect METTL14 after ZFP217 immunoprecipitation ( Figure 5C , bottom), suggesting that METTL3 could be part of multiple dynamic complexes. Notably, ZFP217-METTL3 association was DNAand RNA-independent ( Figure 5D ) because treatment of the nuclear extracts with DNase I or RNase A did not interfere with the precipitation of METTL3 with anti-ZFP217 antibodies.
Mettl3 expression was markedly enriched in ESCs and iPSCs compared with MEFs ( Figure 5E ). Accordingly, Mettl3 mRNA and the mRNA of other members of the m 6 A methyltransferase complex were decreased significantly upon RA-and EB-induced ESC differentiation (Figures 5F and 5G; Figure S4A ). However, Mettl3-depleted ESCs maintained an undifferentiated state with high AP activity and no significant changes in core stem cell factor expression ( Figures S4B-S4D ), suggesting that METTL3 is dispensable for ESC self-renewal and may be involved in other aspects of stem cell biology, as proposed previously (Batista et al., 2014) . Because Mettl3 RNA and METTL3 protein levels were unchanged upon Zfp217 knockdown (Figure S4E) , we sought to analyze whether ZFP217 was affecting METTL3 m 6 A activity in vivo. Therefore, we analyzed m 6 A methylation levels in control and Zfp217-depleted ESCs by using three independent methods: m 6 A immunostaining, dot blot, and (Table S4 ). Comparison between the two conditions revealed an increase of m 6 A sites across 3,586 RNAs upon Zfp217 knockdown ( Figure 6A ). Henceforth, we will refer to these transcripts as the ZFP217-dependent sites. ZFP217-dependent RNAs spanned a wide set of functions ( Figure 6B ) that were enriched in the undifferentiated state, as assessed by gene set enrichment analysis (GSEA) ( Figure 6C ). Next, we overlapped ZFP217-dependent sites with published available MeRIP-seq datasets of Mettl3 knockout ESCs (Batista et al., 2014) . The vast majority of the common peaks (72%) experienced a decrease in m 6 A methylation levels upon Mettl3 knockout and an increase in m 6 A RNA modification after Zfp217 depletion, suggesting that ZFP217 is antagonizing the RNA methyltransferase activity of METTL3 ( Figure 6D ). Interestingly, 25% of common peaks underwent an increase in m 6 A levels in Zfp217-and Mettl3-depleted cells, whereas just 3% of them had a decrease in methylation under both conditions. Methylated m 6 A sites from control and Zfp217-depleted cells were located within a median distance of 30 nt from the nearest consensus RRACU sequence motif (Figures 6E-6F ; Meyer and Jaffrey, 2014). As described previously (Dominissini et al., 2012; Meyer et al., 2012) , m 6 A sites were enriched significantly near the stop codon and the beginning of the 3 0 UTR, with virtually no peaks located at the TSS of the protein-coding genes ( Figure S5A ). The m 6 A enrichment was positively correlated with exon length, with median internal exons harboring sites in Zfp217 shRNA ESCs longer than in control shRNA ( Figure S5B ). To test whether the global increase in m 6 A levels was a consequence of increased transcription upon Zfp217 knockdown, we analyzed the expression of transcripts harboring m 6 A modification in control and Zfp217-depleted ESCs. Our analysis revealed that these transcripts were not differentially enriched upon Zfp217 knockdown ( Figure S5C ), providing strong evidence that ZFP217 modulates m 6 A RNA levels by counteracting METTL3 activity. Because ZFP217 was associated with a large number of RNA binding proteins (RBPs), we sought to test the RNA binding capacity of ZFP217 per se. We performed RNA immunoprecipitation coupled with sequencing (RIP-seq) for ZFP217 and METTL3 and identified 5,933 and 6,971 RNAs associated with ZFP217 and METTL3 (Table S5) , respectively. The vast majority of ZFP217-bound transcripts notably overlapped with the METTL3 transcriptome ( Figure 6G ) and was mainly composed of mRNAs associated with transcription and regulation of transcription (Figures S5D-S5F) . To further explore a connection between the epigenome and the epitranscriptome, we generated enrichment profiles around the genomic region of ZFP217 target genes with ChIP-seq and RIP-seq datasets for ZFP217. ZFP217 occupancy at promoters of genes encoding ZFP217-associated transcripts was higher than in non-associated transcripts ( Figure 6H; Figure S5G) . Moreover, RNAs harboring m 6 A modification experienced higher ZFP217 binding, but not POU5F1 binding, at the TSS compared with transcripts that lacked m 6 A modification ( Figure 6I ; Figure S5H ). Collectively, these findings indicate that ZFP217 tightly coupled epigenetic regulation and m 6 A RNA modification. The observation that RNA polymerase II (Pol II) occupancy was enriched in modified transcripts ( Figure S5I ) suggests that m 6 A deposition might occur in parallel with transcription, although further validation is required.
ZFP217 Regulates the Epitranscriptome of Key Pluripotency Factors Affecting Somatic Cell Reprogramming
To further integrate the global mechanism by which ZFP217 regulates the ESC state, we merged the ZFP217 ChIP-seq dataset with m 6 A ZFP217-dependent transcripts and ZFP217 and METTL3 transcriptomes ( Figure 7A ). We identified the core pluripotency factors Nanog, Sox2 ( Figures S6A and S6B) , Klf4, and c-Myc and other factors with a reported function in ESC maintenance (Table S6) . Interestingly, Wtap, one of the core components of the m 6 A methyltransferase complex, and the ''readers'' Ythdf2 and Ythdf3 were also detected in this group, indicating that ZFP217 might play an active role not just in modulating m 6 A deposition but also in modulating the clearance of this RNA modification. To assess the robustness and reproducibility of our analysis, we performed photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) with ZFP217 antibodies following qRT-PCR. We detected binding of ZFP217 at pluripotency transcripts ( Figure 7B ) but not at U1, which was used as a negative control. Moreover, MeRIP revealed an increase of m 6 A modification at these transcripts upon Zfp217 knockdown ( Figure 7C ; Figures S6C-S6D ), which was associated with a decrease in the lifetime of the Nanog, Sox2, c-Myc, and Klf4 mRNAs ( Figures 7D-7G ), whereas the stability of the non-target transcripts Stat3 and U1 was unaffected ( Figure 7H ; Figure S6E) . Given that the catalytic domain of METTL3 is also involved in RNA recognition (Bujnicki et al., 2002) , we sought to analyze whether ZFP217 was affecting METTL3 binding to RNA and, therefore, its m 6 A methyltransferase activity by performing PAR-CLIP with METTL3 antibodies in control and Zfp217-depleted ESCs. The amount of RNA associated with endogenous METTL3 was increased significantly after loss of Zfp217 ( Figure 7I ; Figure S6F ), suggesting that ZFP217 sequesters METTL3 into an inactive complex. Because loss of Zfp217 led to an increase in global m 6 A levels in reprogramming MEFs ( Figure S6G ), we asked whether concomitant depletion of Mettl3 was sufficient to rescue the impairment of iPSC reprogramming after Zfp217 knockdown. Consistent with the fact that METTL3 is dispensable for inner cell mass (ICM) naive pluripotency established in vivo (Geula et al., 2015) , depletion of Mettl3 in reprogrammable MEFs did not decrease the number of AP-positive iPSC colonies (data not shown). Importantly, depletion of Mettl3 partially rescued iPSC reprogramming in Zfp217-depleted cells (Figures 7J and  7K ; Figure S6H ), suggesting that the increment of m 6 A levels occurring upon Zfp217 knockdown is also a barrier for efficient somatic cell reprogramming.
Collectively, our results show that ZFP217 is required to prevent aberrant methylation of the core pluripotency and reprogramming factors, inhibiting ESC differentiation and promoting efficient iPSC reprogramming. We propose a model in which ZFP217 regulates stem cell maintenance and self-renewal by different mechanisms that are not mutually exclusive and can influence each other ( Figure 7L ). That is, ZFP217 directly regulates transcription of key pluripotency and reprogramming genes, including Nanog, Sox2, Klf4, and c-Myc, and promotes their stabilization by preventing METTL3-mediated m 6 A aberrant methylation.
DISCUSSION
Function of ZFP217 in ESC Self-Renewal and Somatic Cell Reprogramming ESCs represent an invaluable resource to investigate human disease. However, in-depth understanding of the epigenetic and epitranscriptomic mechanisms controlling self-renewal, pluripotency, and transitions to differentiated cell fates is necessary for ESCs to hold great promise for regenerative medicine. Here we conducted detailed multidisciplinary research to characterize the role of ZFP217 in ESCs, and we identified ZFP217 to be essential for maintaining the undifferentiated state by tightly coupling epigenetic regulation and m 6 A RNA modification.
The high Zfp217 expression levels in ESCs and during iPSC reprogramming is a consequence of the direct regulation of ZFP217 by the pluripotency factors NANOG, POU5F1, and SOX2. In addition, we observed severely impaired pluripotency through the downregulation of Nanog, Pou5f1, and Sox2 expression in ESCs depleted of Zfp217, suggesting that ZFP217 is essential in the control of early embryogenesis and that it may operate within an autoactivating feedback loop. Moreover, our results show that depletion of Zfp217 in ESCs results in cell proliferation defects by triggering cell-cycle arrest and apoptosis, which further shifts the self-renewal phenotype toward differentiation.
In this study, we also illustrate the role of ZFP217 in late stages of somatic cell reprogramming, when pluripotency factors are activated. Zfp217 depletion significantly decreases both the number of iPSCs and the efficiency of reprogramming, which is in part due to m 6 A hypermethylation. Three of four of the
Yamanaka factors undergo an increase in m 6
A of mRNAs upon Zfp217 knockdown, affecting their half-life and the reprogramming capacity. In fact, concurrent depletion of both Zfp217 and Mettl3 is sufficient to partially rescue the impairment of iPSC reprogramming upon Zfp217 loss. These observations could position the modulation of Zfp217 expression as a valuable tool for approaching stem cell therapies.
Comprehensive Roles for ZFP217 within an Integrated Epigenetic Regulatory Model Given the broad number of binding regions identified by ZFP217 ChIP-seq, ZFP217 promoter occupancy is not correlated with changes in gene expression. What is the molecular basis for this promiscuous recruitment in ESCs? ZFP217 DNA-binding activity for specific and non-specific sequences is similar, with the exchange rate between the free and bound protein being faster for the nonspecific complex (Vandevenne et al., 2013) . Therefore, ZFP217 would open genomic DNA with its DNA-binding surface, recruiting additional proteins at such sites and, therefore, facilitating the targeting of sequence-specific DNA binding sites among a region of non-specific sites.
Overall, we made different observations in our comprehensive and integrative epigenomic analysis. First, ZFP217 occupancy is highly enriched at TSSs, overlapping with RNA Pol II Ser-5P, suggesting that ZFP217 could be involved in promoter-proximal pausing in ESCs, thereby facilitating co-transcriptional alternative splicing. Indeed, ZFP217 was found to interact with several RBPs involved in most aspects of RNA metabolism, including RNA processing, maturation, and splicing. Second, ZFP217 occupies actively transcribed genes, and, to a lesser extent, ZFP217 can also be located at poised or bivalent promoters of neuroectodermal genes. Third, enhancer and promoter regions of stem cell identity genes are co-occupied by ZFP217, LSD1, and POU5F1. Studies published previously have shown interaction between LSD1 and ZNF217, where ZNF217 is important for LSD1 recruitment at specific genomic locus (Thillainadesan et al., 2012) . On the other hand, most of the POU5F1-associated proteins are transcriptional repressors (Liang et al., 2008 ) that were also found in different reported ZNF217 interactome analyses, suggesting that these proteins could be part of the same transcriptional complex. Ultimately, our work indicates that ZFP217 is required for direct transcriptional activation of the core pluripotency factors. Given that ZFP217 is a bifunctional transcription factor, it is likely that negative regulation of gene expression through ZFP217 is equally important to maintain pluripotency. Understanding the relative contributions of activation and repression could provide fundamental insights regarding the dynamic control of stemness mediated by ZFP217. A methyltransferase complex that has not yet been characterized, our intent was to resolve the ZFP217-METTL3 interaction with our LC-MS/ MS analysis. Importantly, the role of METTL3 in ESCs has only been investigated recently. One model proposes that m 6 A methylation on developmental regulators blocks HuR binding and destabilizes such transcripts, thereby maintaining pluripotency (Wang et al., 2014b) . Other studies postulate that m 6 A is not required for ESC maintenance but for transition of ESCs to differentiated lineages (Batista et al., 2014) . In agreement with the latter observation, Mettl3 knockout epiblasts and naive ESCs are viable at the pre-implantation stage. However, they are unable to exit the naive state at the post-implantation period, leading to embryonic lethality (Geula et al., 2015) . ZFP217 has crucial regulatory functions in m 6 A deposition, adding a layer of complexity to our understanding of the molecular events regulating RNA methylation in ESCs. ZFP217 sequesters METTL3, diminishing METTL3 binding to RNAs. Moreover, the fact that ZFP217 does not interact with METTL4 strongly suggests that METTL3-ZFP217 is held in an inactive complex. How do the cells dynamically control m 6 A RNA modification in ESCs? Conceptually, we propose that, in the undifferentiated state, high levels of METTL3 methyltransferase activity are tightly regulated by ZFP217, preventing core ESC transcripts from aberrant methylation. During cell differentiation, expression of ZFP217 and its target genes decreases rapidly. METTL3 is free and catalyzes m 6 A methylation at the few pluripotency transcripts that still remain, a requirement to exit the pluripotency state. ZFP217 occupancy at promoters of genes encoding ZFP217-bound transcripts and m 6 A-methylated RNAs is higher than at unbound and unmodified transcripts, strongly suggesting that ZFP217 controls different regulatory layers of pluripotency, possibly in a redundant and overlapping manner. Therefore, it is reasonable to think that epigenetic mechanisms may impose the composition of the stem cell epitranscriptome.
In summary, we demonstrate that ZFP217 is critical for the maintenance of ESC self-renewal and somatic cell reprogramming by regulating the transcription of pluripotency genes and preventing such transcripts from aberrant m 6 A methylation.
The direct connection between ZFP217 and m 6 A methylation in maintaining and reacquiring a pluripotent state provides fundamental insights into the post-transcriptional gene regulation network in stem cell biology. Given the emerging prominence of ZNF217 in oncogenesis (Collins et al., 1998; Littlepage et al., 2012) , we suggest that m 6 A modification is relevant in human cancers. Dissecting the molecular mechanisms that mediate these methylation changes in RNA could predict cancer risk, achieve early diagnosis, track the prognosis of tumor fate, and, ultimately, provide novel therapeutic approaches.
EXPERIMENTAL PROCEDURES
For full details, see the Supplemental Experimental Procedures.
Cell Culture and Differentiation Assays CCE murine ESCs were grown under typical feeder-free ESC culture conditions. To induce differentiation with RA, leukemia inhibitory factor (LIF) (eBioscience) was removed, and RA (Sigma-Aldrich) was added at a concentration of 5 mM. EBs were obtained by growing ESCs in low-attachment dishes in the presence of complete medium and without LIF.
Somatic Cell Reprogramming
Early passage MEFs were infected with a single lentiviral stem cell cassette (STEMCCA) constitutively expressing all four Yamanaka factors. The day after infection, MEFs were replated at a density of 50,000 cells/well on irradiated MEF feeder layers and cultured in mouse iPSC medium.
ChIP Assays
ChIP was performed as described previously (Whyte et al., 2012) . The following antibodies were used: anti-ZNF217 (Santa Cruz Biotechnology, catalog no. sc 55351x), anti-OCT3/4 (Santa Cruz, catalog no. sc-8628), and anti-LSD1 (Abcam, catalog no. ab17721).
Analysis of m 6
A Levels RNA m 6 A levels were determined by dot blot, m 6 A immunostaining, and LC-MS/MS as described in the Supplemental Experimental Procedures. m 6 A MeRIP-seq was conducted as described previously (Dominissini et al., 2012) . A aberrant methylation.
PAR-CLIP
Statistical Analysis
All values were expressed as mean ± SD. Statistical analysis was performed by unpaired Student's t test. A p value of less than 0.05 was considered statistically significant.
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